The application of cannabis sativa for the treatment of neurologic and mental disease is expanding. Cannabinoids in Neurologic and Mental Disease collects and presents for the first time recent research involving the use of pharmacological cannabinoids for the treatment of neurodegenerative and neuroinflammatory disease. The neurologic application of cannabinoid therapy builds upon psychiatric and psychological use for the treatment of a variety of core mental disorders. This comprehensive reference on the known uses of cannabinoids will be useful for clinical neurologists, neuroscience and clinical neuroscience researchers, clinical psychologists and psychiatrists and the general medical community. A comprehensive reference on the clinical uses of cannabinoids for treating major neurologic and mental diseasesDetailed coverage of cannabinoid use for neuroinflammatory and neurodegenerative disease including Multiple Sclerosis, Epilepsy, Huntington's disease, Parkinson's disease, and Alzheimer's diseaseDetailed coverage of cannabinoid use for major psychiatric and psychological diseases and disorders including schizophrenia, bipolar disorders, Tourette's syndrome, and post-traumatic stress disorder (PTSD) INDICE: The ever expanding world of the endocannabinoids: a concise introduction - Fabiana Piscitelli and Vincenzo Di Marzo PART I: ROLE OF THE ENDOCANNABINOIDS IN NEUROINFLAMMATORY AND NEURODEGENERATIVE DISORDERS 1. Cannabinoids for the treatment of Neuroinflammation - Maria L. de Ceballos 2. Endocannabinoids and Alzheimer's Disease - Steven George Fagan and Veronica A. Campbell 3. Cannabinoids in Parkinson's Disease - Eilís Dowd 4. Cannabinoids and Huntington's Disease - Cindy Casteels, Rawaha Ahmad, Matheiu Vandenbulcke, Wim Vandenberghe and Koen Van Laere 5. Endocannabinoids and Amyotrophic Lateral Sclerosis - Eva de Lago, Miguel Moreno-Martet, Francisco Espejo-Porras and Javier Fernández-Ruiz 6. Endocannabinoids and Epilepsy - Robert E. Blair, Laxmikant Deshpande and Robert J. DeLorenzo 7. Endocannabinoids and Migraine - Cristina Tassorelli PART II: ROLE OF THE ENDOCANNABINOIDS IN PSYCHOLOGICAL AND PSYCHIATRIC DISORDERS 8. Cannabinoids and Schizophrenia - Cathrin Rohleder and F. Markus Leweke 9. Cannabinoids and Bipolar Disorder - Raphael J. Braga, Sherif Abdelmessih, Juliana Tseng and Anil Kumar Malhotra 10. Cannabinoids and the Tourette syndrome - Kirsten R. Müller-Vahl 11. The Role of Endocannabinoid Function in Posttraumatic Stress Disorder: Modulating the Risk Phenotype and Rendering Effects of Trauma - Francesco H. Gabbay, Kwang H. Choi, Gary Wynn and Robert J. Ursano 12. Cannabinoids and Drug Addiction - Maria Antonietta De Luca and Liana Fattore 13. Cannabinoids and appetite (dys)regulation (Obesity) - Claire M. Williams, Benjamin J. Whalley and Ciara McCabe PART III: ROLE OF THE ENDOCANNABINOIDS IN IMPULSIVE AND COMPULSIVE DISORDERS 14. The cannabinoid system and impulsive behavior - Joost Wiskerke and Tommy Pattij 15. Cannabinoids and compulsive-obsessive disorder - Plinio C. Casarotto, Felipe V. Gomes and Francisco Silveira Guimarães 16. The endocannabinoid system: anorexia nervosa and binge eating disorder - Maria Scherma, Valentina Satta, Walter Fratta and Paola Fadda 17. The Endocannabinoid System and Trichotillomania: A Promising Target for Treatment? - Jon E. Grant, Brian L. Odlaug and Samuel R. Chamberlain 18. CONCLUSIONS: FUTURE PERSPECTIVES Cannabinoid CB2 receptor ligands and their therapeutic potential in mental diseases - Emmanuel S. Onaivi, Hiroki Ishiguro and Qing-Rong Liu
- ISBN: 978-0-12-417041-4
- Editorial: Academic Press
- Encuadernacion: Cartoné
- Páginas: 448
- Fecha Publicación: 29/03/2015
- Nº Volúmenes: 1
- Idioma: Inglés